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ABSTRACT
Inexpensive, sensitive and specific detection of infectious agents is a critical
milestone for preventing disease spread in both the developed and under-
developed worlds. Rapid and accurate detection of pathogens is especially
important for control and treatment of foodborne diseases. According to esti-
mates issued by the Center for Disease Control and Prevention, one out of six
Americans will be sick during this year due to consumption of contaminated
products and there will be 50,000 related hospitalizations. A point-of-care
device capable of performing nucleic acid amplification will enable effective
detection of infectious agents in multiple settings, allowing better enforce-
ment of food safety regulations. Current protocols and practices for control
of agents responsible for foodborne disease will become cheaper, faster and
easier to perform with the incorporation of such devices. Product recalls
and food-related diseases will be reduced with a portable system that allows
producers, retailers, and consumers to detect pathogens in food samples.
In this work, we demonstrate multiplexed detection of food pathogens
through loop-mediated isothermal amplification on a silicon oxide chip. To
our knowledge, this is the first report of miniaturized isothermal nucleic acid
amplification on integrated circuit materials. Inhibition of nucleic acid am-
plification by adsorption of the polymerase by silicon oxide is countered with
silane passivation techniques. Primers for amplification of specific infectious
agents are dehydrated in silicon oxide wells, enabling multiplexed screening of
virulence genes of Listeria monocytogenes, Escherichia coli, and Salmonella.
Droplets of 30 nL with reagents for nucleic acid amplification and lysate
of suspected pathogens are arrayed on micro-machined wells with an auto-
mated microinjection system. We show that dehydrated primers resuspend
when other reagents are microinjected, and specifically amplify the targeted
gene. Results of characterization experiments quantifying detection limit,
specificity and robustness are also presented.
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CHAPTER 1
INTRODUCTION
Medical diagnosis at or near the site of patient care, known as point-of-care
(POC) testing, is an active research field and important progress has been
reported in recent years [1, 2]. There are currently few POC testing meth-
ods available in primary care and emergency room settings. Some of the
most prevalent examples are disposable pregnancy tests and continuous glu-
cose monitoring systems (CGMS). However, there is significant opportunity
for many other exciting applications of such devices. For example, nucleic
acid-based methods are considered the gold-standard for detection and iden-
tification of microorganisms and viruses due to their high specificity and
selectivity. A POC device capable of performing DNA amplification with
techniques such as polymerase chain reaction (PCR) could significantly re-
duce the cost per test, decrease sample volumes, and shorten time to results
in a variety of environments not accessible to most standard laboratory equip-
ment. Nucleic acid based POC systems are currently in their infancy with
significant opportunity for development [3]. Recent technological advances in
micro-fluidics and micro/nanotechnology have enabled new possibilities for
the development of small and sensitive point-of-care ‘lab-on-a-chip’ diagnos-
tic devices capable of providing a rapid analysis of nucleic acid amplification.
Portable diagnostic devices for point-of-care DNA screening are highly de-
sirable in various fields. Two examples are global health initiatives, where
assays take place in resource limited settings, and home testing, where lim-
ited expertise and lab equipment are available. In particular, POC devices
with capabilities of nucleic acid amplification detection (NA-POC tester)
can aid in accurate and rapid diagnosis of infectious agents, which is critical
for preventing the spread of infection [4]. Cost-effective POC devices can
enable inexpensive screening stations with low infrastructure requirements,
enabling development of control networks and on-site detection of infectious
pathogens. There are several scenarios that attest to the significance of the
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NA-POC tester. For example, the food industry spends significant resources
(USDA devotes $ 1 billion dollars a year [5]) controlling agents responsible for
food-borne disease. A POC detection system will allow all parties involved
in food production and commercialization to detect pathogens in products,
thereby reducing or eliminating recalls and food related illnesses. Other im-
portant applications for POC devices include the detection of harmful viruses
in patients. The 2009 H1N1 influenza pandemic could have been averted or
at least controlled if devices for virus screening were present in all airports.
Checkpoints for documentation could have been equipped with screening de-
vices that would detect infected patients and could have prevented the disease
from spreading to other countries.
Porting 40 years of semiconductor technology research into the POC sys-
tem is the key to achieving cost effectiveness, portability and rapid detection
times. Fast thermo cycling, which is pivotal for the construction of PCR
assays in 10 minutes or less, can be achieved using transistors as localized
heaters and small volumes that have rapid thermal cycling capability due to
small thermal mass. Transistors will also enable the electrical detection of
DNA amplification byproducts, eliminating expensive and bulky optical sys-
tems. Currently, nucleic acid amplification is detected with optical systems
querying for fluorescence or turbidity [6, 7]. However, such methods require
complex and expensive equipment (fiber optics, CCD sensors etc.) that in-
crease cost and number of components of the POC device. A system for
nucleic acid amplification will be cheaper, smaller, and simpler if electrical
methods are used to detect amplification products. Field-effect transistors
(FETs) for thermo-cycling and detection of nucleic acid amplification are the
fundamental components of a successful NA-POC tester.
In this study we used an experimental setup composed of a microinjection
system and a silicon oxide chip with micro-machined wells to test protocols
for multiplexed on-chip detection of foodborne pathogens through nucleic
acid amplification. The microinjection system creates nano-droplet arrays on
the wells where the amplification reaction takes place. After passivation and
droplet size optimization, we have been able to amplify genes of foodborne
pathogens using loop-mediated isothermal amplification. We also performed
characterization experiments to quantify sensitivity, specificity and robust-
ness of on-chip nucleic acid amplification. Finally we show that through
primer dehydration techniques it is possible to screen for several pathogens
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on a single array, showing the path for future scaling of multiplexed on-chip
pathogen detection.
Chapter 2 reviews foodborne pathogens and biomolecular assays, the cur-
rent detection protocol, basics of LAMP, and related work on the NA-POC
tester. Chapter 3 describes chip microfabrication, experimental setup as-
sembly and chosen passivation technique to avoid adsorption of LAMP poly-
merase by silicon oxide surface. Chapter 4 shows on-chip amplification results
and experiments that characterized sensitivity, specificity, and robustness of
the detection protocol. Finally, Chapter 5 is devoted for discussion, general
conclusions and outlining future work.
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CHAPTER 2
LITERATURE REVIEW
2.1 Foodborne pathogens and biomolecular detection
Pathogenic bacteria are microorganisms that cause infection and disrupt the
normal function of the body, causing illness. Once ingested, pathogenic bac-
teria will replicate and destroy cells in the body or produce toxins that kill
cells or interfere with their normal physiology [8]. The Center for Disease
Control and Prevention (CDC) estimates that each year roughly 1 in 6 Amer-
icans (or 48 million people) gets sick, 50,000 are hospitalized, and 1,000 die of
foodborne diseases related to pathogenic bacteria [9] . Worldwide, bacterial
infections are still the most common cause of death in undeveloped countries,
accounting for about 40% of deaths [10].
As early as 1906 the United States Department of Agriculture (USDA)
has created organizations to detect, record and prevent outbreaks related to
foodborne pathogens [11]. Since then, legislations and protocols to protect
consumers have been implemented and enforced. The Food Safety and In-
spection Service (FSIS) is a branch of USDA created to combat foodborne
pathogens and has the authority to order recalls when infectious agents are
detected. They are in charge of testing meat and poultry products, imple-
menting controls and monitoring adulterants in food [12]. To enforce regu-
lations and prevent disease spread, agencies like FSIS mainly use microbial
identification techniques for detection of pathogens [3]. Those traditional
processes usually take 1 to 5 days. Thus, by the time pathogens are de-
tected, products may already be available to consumers, risking outbreaks
and infections in the general population. In addition, effective treatment of
an infected patient depends on accurate detection of the pathogen. Unfortu-
nately, long microbial processes retard pathogen diagnosis forcing physicians
to use palliatives while pathogen is being confirmed [13]. Therefore, alterna-
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tive diagnosis methods using biomolecular techniques like polymerase chain
reaction are being used to improve accuracy and time for detection of screen-
ing protocols.
The discovery of the structure of DNA, genome sequencing and studies
of gene-encoding functions have given rise to powerful DNA-based detection
methods. These biomolecular methods have improved the specificity and
sensitivity of foodborne pathogen detection techniques. For example, spe-
cific detection of pathogenic Escherichia coli (E.coli) presented a challenge
with traditional methods. There are 300-400 E.coli serogroups that create
toxins pathogenic to humans. However not all of them have been associ-
ated with human illness, and isolating only harmful types required complex
immunoassays like ELISA [14]. During the 1990s, biomolecular studies of
patients presenting infection symptoms revealed that the ability to produce
Shiga toxin does not by itself render E. coli pathogenic; the presence and
expression of additional virulence factor genes is required to cause human
illness [15]. Using DNA amplification methods it is possible to target genes
that are related to human disease, thereby specifically detecting, in a faster
and simpler assay, only microorganisms that represent risk to humans.
2.1.1 Pathogenicity island (PAI)
When patients are diagnosed with food poisoning due to bacterial infection,
it is necessary to identify the pathogen to provide accurate treatment and
track the infection source. From these investigations, genetic characteristics
of virulent agents have been recorded. For instance, now it is well charac-
terized that there are two main requirements for an E.coli serogroup to be
pathogenic. It needs to produce Shiga toxin and have the ability to attach
to enterocytes lining the intestinal tract. In this way, consumed Shiga toxin
producing E. coli remains in the intestine while secreting the toxin producing
food poisoning [16]. When an E.coli strand has genes that allow it to fulfill
those requirements it is considered part of a pathogenicity island (PAI) and
therefore declared pathogenic. For pathogenic E.coli, this means that it needs
to possess Shiga toxin genes (stx1 or stx2); and genes encoding for intimin
(eae), the intimin receptor (tir), and a secretion system (esp) [16]. Similarly,
virulent genes that compose PAI have been identified for L. monocytogenes
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[17], salmonella [18] and other pathogens.
Using bimolecular techniques it is possible to detect and identify pathogens
from food samples with outstanding figures of sensitivity and specificity. Cur-
rent detection protocols rely on DNA amplification methods like PCR to
detect and identify pathogens present in food samples. However, as will be
reviewed in the next section, current federally approved detection protocols
still have stages for confirmation through immune-based assays and tools for
DNA amplification are expensive and require trained personal. There are big
opportunities and important challenges to make detection protocols faster,
cheaper and more effective.
2.2 Description of USDA screening protocol
Figure 2.1 summarizes the USDA protocol [19] for detection and confirma-
tion of food pathogens in meat samples. It is a process that takes up to 4
days, requires specialized equipment (in particular the Applied Biosystems
7500 Real-Time PCR System that is about $70,000), laboratory space, and
trained personnel. In this section we briefly describe the USDA protocol and
point out phases that will be improved with the development of a reliable
and affordable NA-POC tester.
The last release, in June of 2012, of the USDA laboratory guidebook for de-
tection and isolation of pathogens from meat products is a l6 page document
that describes equipment, quality control measurements and procedures to
detect pathogens in food. The process begins with the digestion and filtering
of a 325 g food sample followed by a primary enrichment. Incubation for
15-22 hours will increase the colony forming units (CFU) count, enabling
detection through PCR. USDA guidelines require each group of samples to
include a positive and a negative control during sample preparation and en-
richment.
After inoculation, an initial PCR screen aims to detect the presence of
genes associated with virulence factors of pathogenic bacteria (i.e. stx and
eae for E.coli ). If the detected genes match a pathogenicity island (PAI),
the sample is then plated and inoculated for isolation. Immunomagnetic
separation (IMS) using functionalized beads with antibodies specific to the
detected pathogen is recommended by USDA as the isolation method. After
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magnetic beads specifically bind to the target pathogen, separation magnets
isolate the agent of interest. Washing steps and acid treatments will eliminate
background flora for a final incubation with only the suspected infectious
agent.
Lysate from the last inoculation is used to confirm pathogen presence and
identity. In this final step, VIKTEK and PCR are used as complementary
detection techniques. VIKTEK performs biochemical identification by ob-
serving agglutination of colonies that are inoculated in sheep blood agar
(SBA). PCR is used to amplify for a second time virulence genes, and to
detect the presence of antigens specific to the suspected pathogen. If both
biochemical and biomolecular assays are positive, the sample is considered
contaminated and recall orders are issued.
Inclusion of a NA-POC tester in the USDA laboratory guide protocol will
not significantly reduce detection time. Most of the time in this protocol is
spent in incubation and enrichment of samples, which is still unavoidable.
However, an NA-POC tester will reduce equipment cost, eliminate the ne-
cessity of trained personnel and relax infrastructure requirements. The three
PCR steps along the detection protocol will be simpler, cheaper and faster
with a point-of-care diagnostic system. In addition, the increasing specificity
of biomolecular assays could eventually eliminate the need for IMS isolation,
reducing cost and time for results.
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2.3 Loop-mediated isothermal amplification (LAMP)
First reported in 2000 by Eiken [20], Loop-mediated isothermal amplifi-
cation (LAMP) is a novel nucleic acid amplification method that uses an
auto-cycling strand displacement DNA synthesis performed by the Bacillus
stearothermophilus (Bst) polymerase. There are several reports that demon-
strate detection of pathogenic microorganisms using LAMP [21, 22, 23, 24].
This section briefly summarizes LAMP mechanisms, primer design, and key
features.
2.3.1 Amplification mechanism
LAMP employs a strand-displacing Bst DNA polymerase and a set of primers
designed to fold and create dumbbell shaped DNA structures that initial-
ize the reaction [20]. At LAMP reaction temperature (60 − 65 ◦C) double-
stranded DNA is in ‘dynamic equilibrium.’ In this stage LAMP primers can
anneal to the complementary sequence in the target double-stranded DNA
and the polymerase will make initial elongations. While the displacement
polymerase elongates DNA, it releases a single-stranded DNA that is then
used to form more copies or create loop structures. After six steps of anneal-
ing, elongation and displacement, a structure with stem-loops at each end
(dumbbell structure) is created (Figure 2.2). This structure is the starting
element for isothermal amplification.
Figure 2.2: Dumbbell DNA structure that initiates LAMP amplification
The dumbbell-like DNA structure will be converted into a stem-loop DNA
structure made of copies of the original template when amplicons self-prime.
Afterwards, inner primers (FIP and BIP) anneal to the single-stranded re-
gion in the stem-loop DNA and the polymerase will elongate, displacing
and releasing the previously synthesized strand. This released single strand
forms a new stem-loop structure in the 3’ end and DNA synthesis starts
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using self-structures as a template. FIP and BIP primers continue creating
stem-loop structures keeping the reaction active and DNA synthesis contin-
ues displacing double-stranded DNA sequence. The reaction will stop when
concentration of free deoxyribonucleotides is too low or the buffer capacity
is reached. As a result of this 20-step process, variously sized DNA struc-
tures (consisting of concatenated inverted repeats of the target sequence) are
formed. The process is described in (Figure 2.3) and detailed videos and
schematics can be found on-line [25].
Figure 2.3: Schematic representation of LAMP reaction mechanism [20]
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2.3.2 Primer design
LAMP employs a set of two specially designed inner (FIP and BIP) and
outer (F3 and B3) primers. Two more loop primers (LF and LB) are usu-
ally included in the reaction mix to increase sensitivity and accelerate the
reaction, yielding shorter detection times [26]. Designing a set of six primers
that are specific for a target sequence and do not anneal among themselves
is a complex task that requires computer-assisted design.
LAMP primer design is done using PrimerExplorer (www.primerexplorer.jp).
This web-based software receives as an input a text file with the target DNA
sequence that can be found in gene data bases like GenBank, and it gives
multiple primer sets that would amplify the target sequence. Selection of the
most appropriate set of primers is done by checking the specificity of primer
sequences using sequence matching calculators like NCBI BLAST (Basic Lo-
cal Alignment Search Tool). However, laboratory testing is needed to find
the most specific and effective design of primers.
2.3.3 Key features
LAMP was developed as an alternative nucleic acid amplification technique
that did not require complex laboratory instrumentation or an elaborate
method for detection of the amplified products. LAMP is isothermal and
therefore does not require complicated thermal cyclers. In addition, LAMP
results can be observed by a visual assessment of turbidity or by addition
of fluorescent reagents (like SYBR green) for simple assessment of positive
amplification.
Isothermality and visual assessment of amplification are the two main fea-
tures of LAMP. But other important characteristics are:
• Low detection limit: As few as 1 copy per reaction has been detected
using LAMP assays.
• High specificity: Because 4 primers need to anneal to the target DNA
(instead of only 2 from PCR), the likelihood of nonspecific amplification
from different strands or primer dimmers is lower.
• Assay time: Lamp assays can give detection results in as little as 10
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- 15 min, depending on the initial template concentration, and using
LF/LB loop primers it is possible to decrease a long detection time.
• Amplification yield: While PCR yields 10 µg/mL of DNA copies,
LAMP produces 500 µg/mL, allowing detection through turbidity mea-
surements.
Overall, LAMP has been proposed as an ideal technique for nucleic acid
amplification for point-of-care devices since it has less demanding equipment
and has better sensitivity and specificity over PCR and other methods. How-
ever primer design is more complex and reagents are more expensive. We
used this method for initial on-chip detection of foodborne pathogens and
studies of biocompatibility between silicon oxide and nucleic acid amplifica-
tion.
2.4 Devices for point-of-care (POC) DNA amplification
Standard microbiological detection techniques require days of labor and many
organisms cannot be identified [7]. With molecular testing (and in particular
PCR) detection in clinical laboratories is faster, broader and less labor inten-
sive. However, existing technologies for molecular testing require specialized
facilities and equipment. Therefore, in order to make molecular diagnosis
available to the general public and given broad advantages of point-of-care
diagnosis in several scenarios, various research groups and companies have
been working on systems that reduce assay complexity and facility require-
ments. In this section we will briefly review the reported systems that aim to
allow simpler and cheaper nucleic acid-based detection of pathogens. Here
we review state-of-the-art technologies and identify possible improvements
using the technology we are developing.
An ideal DNA amplification based point-of-care pathogen detection system
should [27]:
• Be automated so it can be operated by untrained personal and minimize
human induced error.
• Have small footprint or be portable in order to relax facility require-
ments and allow point-of-care diagnosis.
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• Be able to detect a broad range of pathogens and perform multiplexed
detection assays.
• Have acceptable sensitivity, specificity, precision and detection limit to
give relevant clinical diagnosis.
Three recent publications [7, 28, 29] have reported systems that try to in-
tegrate all the previous requirements (Figure 2.4 ). All of these devices use
microfluidics for automated sample loading, simplifying the assay and reduc-
ing size of equipment. They can do parallel screening of multiple pathogens
and detect pathogens through DNA amplification techniques for low detec-
tion limits and high specificity. However, all these systems still rely on flu-
orescence detection for nucleic acid amplification assessment and use Peltier
or resistive heating for sample thermal cycling. Thus, they need optical sys-
tems and complex temperature control elements that make the system larger
and more expensive. Using field-effect transistors for heating and sensing can
improve NA-POC devices.
Figure 2.4: Current alternatives for automated point of care DNA testing
2.4.1 FilmArray, IdahoTechnology Inc.
Idaho technologies offers an ‘automated nested multiplex PCR system.’ The
system is composed of a polypropylene microfluidic pouch and instrumenta-
tion for PCR thermo-cycling and fluorescence detection. This is the most
complete commercial solution for small footprint, fully automated, PCR de-
tection assays. It is the only system capable of automated sample prepara-
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tion and it offers multiple analysis tools. One of the main components of
this system is a disposable pouch made from polypropelene with reservoirs
and channels for PCR assay stages. Figure 2.5 is a schematic with reser-
voirs, chambers and connections that are used for PCR amplification. Three
important characteristics of the pouch are:
1. Primers have been dehydrated in the array for 2nd stage PCR for mul-
tiplexed screening.
2. Pouch is sealed shut under vacuum to avoid valves or fluidic controls.
3. Reagents needed for reaction (buffers and fluorophores) are frozen dried
in reservoirs that allow later rehydration and automated sample prepa-
ration.
Figure 2.5: Schematic of FilmArray microfluidic pouch [7]
FilmArray has three pneumatic elements that move liquid through the
pouch. Heating of first and second PCR stages is done with two separate
Peltier devices for thermo-cycling. The fluorescence detection system is com-
posed of a blue LED that illuminates the second stage PCR and a digital
camera that records fluorescence of chambers in the second stage PCR.
FilmArray comes with primers for detection of 21 different viral and bac-
terial respiratory pathogens. Idaho Technologies reported a sensitivity and
specificity acceptable for medical diagnosis without any further specification.
The biggest highlight of this system is that cell lysis and DNA extraction are
performed in the pouch, reducing required sample preparation before sam-
ple is injected. The tool is also able to perform and record melting curve
analysis.
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2.4.2 Point-of-care testing system, Sony Corp.
Sony reported in 2010 a device for detection of respiratory infectious agents.
Their system is portable, has been used for both PCR and LAMP amplifica-
tion, and is capable of screening up to nine different genes in a sample that
is automatically loaded inside a microfluidic polydimethylsiloxane (PDMS)
channel.
This system has not been commercialized but it promises to be an in-
expensive and automated solution for point-of-care diagnostics. It comes
with a customized minicomputer for fluorescence detection recording. Un-
like the Idaho Technology system, sample preparation must be done off-chip
but other stages take place inside the device. The sample cocktail is loaded
into a microfluidic PDMS chip that has been sealed in a vacuum. Differential
pressure between PDMS chip and atmosphere will force the flow inside the
microfluidic chambers where primers for infectious agents have been dehy-
drated and the reaction takes place. After the sample is loaded, the control
mini-PC will set different temperatures to run DNA amplification using a
Peltier heater. DNA amplification is observed with intercalating dyes like
SYBR green. Fluorescence is detected through photodiodes that are aligned
to each microfluidic chamber and change electrical resistance / current when
amplification is positive.
With this system Sony Co. demonstrated detection of influenza (FluA,
ACBT and H) in less than 30 min. However, little information on specificity
and sensitivity was provided. The system comes with portable electronics
and could be modified to screen for other infectious disease like tuberculosis
and HIV.
2.4.3 Gene Z, Michigan State University
In February 2012, the Environmental Genomics Lab of Michigan State Uni-
versity reported a device for point-of-care genetic testing. Named Gene-Z,
the prototype is composed of:
1. A disposable polyester microfluidic chip with frozen regents (buffers,
fluorophores and primers) in 1 µL reaction reservoirs
2. Integrated LEDs and optical fibers system for fluorescence detection
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3. Customized aluminum resistive-heater
4. Microprocessors for wireless communication with an Ipod touch
The microfluidic chip has four arrays with 15 chambers each. To target
multiple pathogens, several primers are dried in each chamber (target genes
were eaeA / stx2 for E.coli; and MecA / vicK for S. aureus). To load sample
inside the microfluidic chip, a regular 200 µL pipettor is used to inject 30 µL
of solution that fill all chambers in the array in few seconds due to capillary
forces.
The fluorescence system has 64 individually addressable green LEDs (one
per chamber) and 64 polymer optical fibers for collection of emitted fluores-
cence. The chip and optics system are aligned so that each LED is placed
directly below the reaction well and optical fibers are against reaction wells.
The fluorescence signal is transduced with a CCD sensor that then stores
fluorescence information in a microprocessor.
Alignment between the microfluidic chip and the rest of the systems is
easily achievable with an aluminum heater that is fabricated with negative
polyester chip features. LEDs and optical fibers were embedded and epoxied
into the bottom of the heater and in consequence chambers are automatically
aligned to the correct LED for fluorescence measurements. This configura-
tion also optically isolates each reaction well, preventing optical cross-talk
and errors due to optical contamination. A serpentine resistance across the
aluminum block acts as heat source and a thermocouple is used to monitor
temperature.
Finally, a microcontroller is used for both temperature control and wifi
communication with an Ipod touch that is running an application for auto-
mated sorting of raw data and real-time plotting. A block diagram of the
Gene-Z system is presented in Figure 2.6
Of the three systems reviewed, Gene-Z is the only one that comes from a
noncommercial research project, and therefore more performance details are
available in the literature. Here we summarize five characterization experi-
ments reported by this group that served us as a guideline for characterization
of our detection method.
• Cross-contamination between chambers. The microfluidic chip of this
system has no valves and therefore there is no flow control. In or-
der to assure there was no cross-contamination between reaction wells,
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Figure 2.6: Block diagram of Gene-Z system [28]
chambers are preceded by very long and narrow high fluidic resistance
channels that prevent backflow of fluids from the chamber. Experi-
ments that intercalated negative and positive controls demonstrated
the effectiveness of this approach.
• Optical cross-talk. When using unfocused light sources (like LEDs),
light can travel through transparent polymers. Optical cross-talk be-
tween adjacent reaction chambers was prevented by placing the polyester
microfluidics and reservoirs on top of the non-transparent aluminum
heater. Again, experiments of intercalating positive and negative con-
trols proved this approach successful.
• Reproducibility. Equal distribution of sample among reaction cham-
bers was observed. Also, variation of the detection time for LAMP
assays ranges around 5.9 % within a chip and between different chips.
The average threshold time between three chips was 8.6 +/- 0.7 min,
showing that the system is capable of reproducible detection times for
different pathogens and chips.
• Detection limit. Thirteen was the minimum number of copies detected
per reaction well. However, only 3 out 15 reaction wells showed am-
plification for a false negative ratio of 80%. When a template had a
concentration yielding 135 copies per reaction, all reservoirs showed
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amplification.
• Parallel detection of multiple pathogens. The chip is composed of four
arrays, each with 15 reaction chambers. Primers for E.coli and S. aureus
were dehydrated in chambers and different templates were injected in
each array. Correct identification of the target was demonstrated when
only wells with matching primers and template showed fluorescence
increments.
So far, Gene-Z is the closest to meeting all four goals stated at the begin-
ning of this section. It is portable and multiplexed (allows loading of multiple
samples), and reported characterization experiments demonstrated accept-
able figures of sensitivity and specificity. On the other hand, FilmArray is
not portable and the system from Sony Co. has a single input, restricting
the number of samples that can be tested. However, as was discussed in
the introduction, using semiconductor technology in NA-POC testers opens
opportunities of localized heating and electrical detection. Neither Gene-Z
nor any of the other reviewed systems is compatible with integrated circuit
fabrication methods. Therefore, research on integration of silicon-materials
and nucleic acid amplification is needed to improve POC diagnosis.
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CHAPTER 3
MATERIALS AND METHODS
3.1 Chip microfabrication
Nucleic acid amplification experiments have been performed in a silicon oxide
chip with wells etched by wet anisotropic etch. In this section the microchip
fabrication protocol is described and some characterization measurements
are presented.
Figure 3.1 presents a flow diagram for fabrication of silicon oxide wells that
is described below. Undoped silicon wafers (University Wafers, South Boston,
MA) are used as substrate. After 8 min of piranha clean (1:1 H2O2-H2SO4)
a 160 nm layer of silicon oxide is grown in a furnace (Lindberg/Tempress
Model 8500) at 800 ◦C for 20 min. Positive AZ1518 photoresist (AZ Elec-
tronic Materials, Branchburg, NJ) is spin-coated to form a 2 µm layer on
both the polished and unpolished sides of the wafer. Photoresist is soft-
baked for 8 min in a hotplate at 110 ◦C and etching openings are exposed in
the photoresist using an ultraviolet lamp and a high-resolution transparency
mask (FineLine, Raleigh, NC). Figure 3.2 presents a photolithography mask
design to define openings of oxide for silicon etch. Exposed regions are then
removed by developing the wafer in MIF AZ300 (AZ Electronic Materials,
Branchburg, NJ) for 2 min. Silicon oxide uncovered by photoresist is etched
in 10:1 buffered oxide etchant (VWR, Chicago, IL) for 10 min revealing sili-
con. Leftover photoresist is removed in a Remover PG (MicroChem, Newton,
MA) bath at 70 ◦C for 30 min leaving a silicon oxide mask in the polished
side of the wafer and a protective oxide layer in the bottom side for following
anisotropic etch.
Anisotropic etch of silicon in tetramethylammonium hydroxide (TMAH)
for 24 hours at 70 ◦C creates inverted square pyramids where LAMP ampli-
fication reactions will take place. For passivation purposes 10 nm of silicon
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Figure 3.1: Fabrication flow cross-section schematics. Anisotropic etch of
silicon yields inverted square pyramids where LAMP reactions take place.
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Figure 3.2: Autocad render of transparency photolithography mask for
microwells fabrication
oxide are grown for 2 min at 800 ◦C. Finally, a photoresist protective layer
is spin-coated and soft-baked before wafer is diced in 1 cm x 1 cm squares.
Figure 3.3 shows optical images and profilometer measurements of fabri-
cated silicon oxide microwells.
3.1.1 Silicon oxide surface passivation
Several publications discuss the inhibitory effects of silicon and silicon-related
materials on nucleic acid amplification mainly caused by adsorption of the
polymerase [30, 31, 32, 33]. These adverse effects are especially notable in
small reaction volumes (i.e. microfluidic or on-chip amplification) due to
large surface-to-volume ratio that exacerbates molecule adsorption. Along
with studies of amplification inhibition, it is possible to find passivation tech-
niques that prevent inhibition by adding reagents to the solution (dynamic
passivation) or changing silicon materials surface properties (static passiva-
tion). Studies that compare dynamic and static passivation point out that
dynamic passivation is less efficient than static [34]. Therefore, for our studies
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Figure 3.3: Optical image and profilometer measurements of fabricated
silicon oxide wells
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we have used static passivation techniques for on-chip amplification looking
for high amplification efficiency.
The static treatment of the surface involves pre-coating during chip fabri-
cation or immediately before use, with one of the following substances:
• Silicon oxide
• Bovine serum albumin (BSA)
• Polyethylene glycol (PEG)
• Silanizing agents (for example 3-glycidoxypropyl trimethoxysilane,
dichlorodimethylsilane, Sigmacote or trimethylchlorosilane)
To prevent inhibitory effects we silanize the silicon oxide wells using Sig-
macote. Thus we are effectively combining two passivation layers aiming to
minimize any inhibitory effect when performing nanodroplet amplification.
Silicon oxide is thermally grown in the last fabrication step (see Figure 3.1)
and the chip is immersed in Sigmacote previous microinjection of LAMP
reagents. Sigmacote is a solution of chlorinated organopolysiloxane in hep-
tane. Organopolysiloxanes (Figure 3.4) are polymers with hydrocarbon sil-
icon moieties and oxygen chains with hydrocarbon moieties [35]. Sigmacote
reacts with the surface silanol groups and binds covalently to the substrate.
We chose Sigmacote as the passivation layer due to reported high amplifi-
cation yield [36] and passivation protocol simplicity. Sigmacote passivation
has only one step and can be completed in less than 5 min.
Figure 3.4: Organopolysiloxane chemical structure
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3.2 Experimental setup
The experimental setup for on-chip detection of food pathogens is composed
of the silicon oxide microchip described in the previous section and an auto-
mated microinjection system. In this section the equipment and automation
scripts of the microinjection system are described. Using a customized setup,
the silicon oxide wells array is filled with 30 nL of reagents for LAMP am-
plification.
There are a few commercial solutions for spotting arrays of nanodroplets
[37, 38]. However, all these tools have large dead volumes (milliliters of
solution that are used to fill reservoirs but cannot be used for droplets) or the
system does not allow alignment of the surface. LAMP reagents are expensive
and reaction volumes do not exceed 100 µL, making it unaffordable to lose
milliliters in dead volume. Also, commercial systems are usually designed to
fill standardized culture plates and have a fixed separation between droplets
that is too big for our microarray. Then, experiments were performed using
a customized system for alignment, arraying and injection of nanodroplets
in silicon oxide chip that is described in Figure 3.5.
The microinjection is done with an IM-300 microinjector (Narishige Scien-
tific Instrument Lab. Tokyo, JP) that fills an Eppendorf VacuTip (Eppen-
dorf. Hamburg, De) that has an internal diameter of 15 µm. After reagents
are sucked into the tip, injection of 30 nL droplets is achieved pressurizing
with air for 20 ms with 60 psi. X, Y and Z movement of the tip, required
for alignment and automatic filling of all wells, is done with a precision po-
sitioning system MCL (World Precision Systems, Sarasota, FL). After the
user visually aligns two points of the array (usually first and last position),
automation scripts will calculate position of all wells and automatically move
the tip to the next well after the nanodroplet is injected.
The system is controlled using a Matlab (MatWorks, Natick, MA) script
that communicates with the equipment through serial and GPIB protocols.
The script injection parameters are input into a graphical user interface
(GUI) that is presented in Figure 3.6. The script (detailed code is in Ap-
pendix A) has the following progression:
1. Input of parameters: User inputs parameters of injection time, X and
Y separation between wells, motor speed and surface position on the Z
axis.
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Figure 3.5: Experimental setup for arraying of nanodroplets in silicon oxide
wells
Figure 3.6: GUI of automated microinjection script
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2. Alignment: The first well (upper left position) will be considered the
origin (0,0). The user needs to align the origin using a microscope and
signal the system to set coordinates at (0,0,0). The second alignment is
also done with a microscope using the absolute move window in Figure
3.6.a. The user input X and Y coordinates of the chosen alignment
position in the injection GUI.
3. Injection and arraying: After second point alignment, the script will
move the tip back to the origin and trigger injection by switching the
DC source voltage from 5 to 0 V. Injection is followed by a system
pause that lets nanodroplets settle inside the well. Then, the tip is
moved to the next position in the array. The script fills from left to
right along each row in the array.
4. Finish or refilling: After injection in rows and columns is completed,
the tip is raised and moved to an edge to allow the user to clear any
leftover solution and refill with new reagents. This step is frequently
necessary to have positive and negative controls in one assay.
Once all the silicon oxide wells are filled, the chip is transferred to a heated
stage controlled with an mK1000 Series High Precision Temperature Con-
troller (Instec. Boulder, CO). The stage will heat up the chip to the reaction
temperature of 65 ◦C while fluorescence images are taken with a Nikon Eclipse
FSI (Nikon Instruments inc. Melville, NY) microscope using a FITC filter
(λ= 495 nm). Pictures are taken every minute using a shutter driver (Vincent
Associates, San Diego, CA) that is controlled with a second Matlab script
that also triggers a Nikon DS-Qi1 camera. The script uses serial communica-
tion for the shutter driver and Java Script functions to control NIS elements
(http://www.nis-elements.com). This script is described in Appendix B and
receives inputs from the GUI in Figure 3.7.
The system described above has allowed us to automatically array nan-
odroplets in the silicon oxide chip. This is a very versatile microinjection
system that allows us to inject multiple LAMP solutions (e.g. with and
without template) in several array configurations. Dead volumes are in the
order of 1- 5 µL minimizing reagents waste. Also, since the arraying process
is automated, this system can easily be used for large scale arrays. Automa-
tion of shutter and image acquisition had allowed us to take a large number
26
Figure 3.7: GUI for real time fluorescence image of LAMP amplification
of images in each experiment improving the resolution of real time amplifi-
cation monitoring. This setup was used to determine performance of on-chip
LAMP amplification letting us array nanodroplets with multiple pathogens,
different template concentrations and negative controls.
3.3 LAMP primers and detection protocol
On-chip detection experiments are divided into four phases: reagent mix,
chip preparation, microinjection and real-time fluorescence imaging. In this
section each experimental phase is described.
3.3.1 LAMP solution preparation
The first step is to prepare LAMP reagents and buffers for later microin-
jection in silicon wells. For each experiment, 30 µL of LAMP solution are
prepared with the following concentrations:
1. Betaine 800 mM
2. Mix of dNTPs 1.4 mM
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3. Isothermal buffer 1 x (Mix of Tris-HCl 20 mM, Ammonium Sulphate
10 mM, Titon-X 8 mM, Potassium chloride 20 mM)
4. Magnesium sulfate 8 mM
5. Primer mix 1.6 µM
6. Bacillus stearothermophilus (Bst) 2.0 WarmStart polymerase 0.64 unit/µL
7. Evagreen fluorescent dye 20 µM
8. Template DNA (variable concentrations)
Reagents 1-4 are commercially available (New England Biolabs, Ipswich,
MA). Primers used for these experiments come from journal articles that
report LAMP primers design and optimization. Primers for amplification
of virulence genes of pathogenic E.coli, listeria and salmonella are listed in
Table 3.1. The primer mix was prepared with custom DNA oligomers (In-
tegrated DNA technologies, Coralville, IO) and mixed with the following
concentrations: FIP/BIP 19 µM; F3/B3 2.4 µM; and LF/LB 9.6 µM.
Instead of wild-type Bst DNA polymerase we use Bst 2.0 WarmStart poly-
merase (New England Biolabs, Ipswich, MA). This is an in-silico designed
homologue of Bst DNA polymerase that was designed as a robust enzyme
with higher thermal stability and salt tolerance, ideal characteristics for on-
chip amplification.
The final component of LAMP reaction mix is the template for positive
control samples. The template for amplification is genomic DNA extracted
from an E.coli O157:H7 culture in bovine brain heart infusion (Sigma-Aldrich.
St. Louis, MO). Bacteria is incubated for 18 hours to reach a concentration
of 109 CFU/ml confirmed by plating. After incubation, 1 ml of cultured
bacteria is centrifuged at 10000 RPM for 3 min to pellet bacteria and remove
media. Bacteria cells are re-suspended in nuclease-free water (Invitrogen,
Grand Island, NY) and heat-lysed at 95 ◦C for 15 min in a thermal shaker.
A final centrifugation at 12000 RPM for 10 min pellets undesired cell debris
leaving in the supernate clean DNA that is used as the template for LAMP
solutions.
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Table 3.1: LAMP primers used in this study. Target genes were stx2 / eaeA
for Escherichia coli, hlyA for listeria monocytogenes, and invA for
salmonella
Pathogen (Gene) Primer Sequence (5’-3’) Source
E.coli F3 GAGATATCGACCCCTCTTG [28]
(stx2) B3 AATCTGAAAAACGGTAGAAAGT
FIP TCCACAGCAAAATAACTGCCCA
ACATATATCTCAGGGGACCA
BIP GATGTCTATCAGGCGCGTTTTGC
CGTATTAACGAACCCGG
LF TGT GGTTAATAACAGACACCGATG
LB ACCATCTTCGTCTGATTATTGAGC
E.coli F3 AGCTCTAACAATGTACAGCT [39]
(eaeA) B3 AGTTGCAGTTCCTGAAACA
FIP GTCTTATCCGCCGTAAAGTCCG
CCGTTCTGTCGAATGGTC
BIP CTAAAGCGGATAACGCCGATACCC
AGGGACATTAGCCTGAG
LF CCCAACCTGGTCGACAACTT
LB ATTACTTATACCGCGACGGTGAA
L. monocytogenes F3 TTGCGCAACAAACTGAAGC [40]
(hlyA) B3 GCTTTTACGAGAGCACCTGG
FIP CGTGTTTCTTTTCGATTGGCGTCT
TTTTTTCATCCATGGCACCACC
BIP CCACGGAGATGCAGTGACAAATGTT
TTGGATTTCTTCTTTTTCTCCACAAC
LF TAGGACTTGCAGGCGGAGATG
LB GCCAAGAAAAGGTTACAAAGATGG
Salmonella F3 CGGCCCGATTTTCTCTGG [22]
(invA) B3 CGGCAATAGCGTCACCTT
FIP GCGCGGCATCCGCATCAATA
TGCCCGGTAAACAGATGAGT
BIP GCGAACGGCGAAGCGTACTG
TCGCACCGTCAAAGGAAC
LF GGCCTTCAAATCGGCATCAAT
LB GAAAGGGAAAGCCAGCTTTACG
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3.3.2 Chip preparation
Prior to use, silicon oxide chips are degreased (acetone, isopropanol, water) to
prevent any organic contamination. Then a thin hydrophobic silane layer is
coated on the chip surface with a 5 min dip in Sigmacote (Sigma-Aldrich. St.
Louis, MO) followed by an isopropanol rinse to remove residues. Afterwards,
for dehydrated primer experiments, 15 nL of primer mix are microinjected
in silicon oxide wells using the same microinjection protocol described in the
previous section but with an injection time of 10 ms. Primers are dried inside
wells at room temperature after 15 min. Finally, to prevent evaporation of
nanodroplets, the chip is immersed in mineral oil. This step must be done
before injection of LAMP solution to avoid cross-contamination. Figure 3.8
summarizes primer dehydration, chip encapsulation and microinjection of
reagents.
3.3.3 Microinjection of LAMP solution
The automated microinjection system is used to fill wells with LAMP solu-
tion. Input pressure for the microinjector needs to be 60 +/- 3 psi for correct
injection and tip filling / clearing. The tip is filled for 10 s to load the tip
with approximately 2.5 µL of reagents. Then, the user sets all the parame-
ters in the injection GUI (Figure 3.6) and runs the alignment process before
the automated injection protocol starts. For experiments with two injected
LAMP solutions (i.e. positive and negative controls in the same array) the
Vacutip was cleared and refilled three times with DI water and IPA to avoid
cross contamination.
Figure 3.8: Schematic of primer dehydration in silicon oxide wells and
mineral oil encapsulation
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3.3.4 Real time measurements
The automated shutter and camera took pictures every minute to record
fluorescence intensity during amplification. Fluorescence images were taken
with NIS-Elements 3.4 (Nikon Instruments inc. Melville, NY) using a FITC
filter, ND front filter at 4, ND back filter at 1 and an analog gain of 8x.
Images were sequentially saved for posterior analysis.
3.4 Data analysis
Assessment of DNA amplification is done using Evagreen (Biotium, Inc. Hay-
ward, CA) a fluorescent dye that binds to double-stranded DNA and is fre-
quently used for PCR analysis [41]. The larger the number of DNA copies, the
more intense is the fluorescence emission at a FITC wavelength (λ = 495 nm).
Fluorescence images are analyzed in ImageJ (http://rsb.info.nih.gov/ij/) us-
ing Raw Integrated density “RawIntDen” which does an uncalibrated sum
of the values of the pixels in the image or selection [42]. Intensity for all
positions in the array is measured using the stack-measurement plugin that
creates an Excel file that is then imported to Matlab for further analysis.
A Matlab script (code in Appendix C) imports the Excel file generated
by ImageJ and creates a matrix with a number of columns equal to wells in
the array and one row for each picture taken. This matrix is populated with
normalized fluorescence intensities, normalizing with the first recorded value
(i.e. first value is set at 1). The Matlab code will generate plots of time
vs. normalized relative fluorescence units (RFU), and the mean of threshold
times and their standard deviation is calculated. The threshold is manually
defined by the user selecting a value between 1.2 and 1.4 (20 to 40 %) of
fluorescence intensity increment that is above noise levels. For experiments in
this report, threshold RFU was set to 1.2 (20% fluorescence increase) or 1.35
(35% fluorescence increase) for experiments where nonspecific amplification
was observed.
Analysis of threshold times in sensitivity experiments was done using the
derivative of fluorescence intensity over time (see Figure 4.3.a on page 35).
Threshold time was defined as the time of maximum derivative. In this way
it is possible to see small differences in threshold times.
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CHAPTER 4
RESULTS AND DISCUSSION
4.1 On-chip amplification of pathogenic E.coli stx2
gene
First experiments aimed to prove reproducible on-chip amplification in a
silicon oxide well. Primers for detection of stx2 gene from pathogenic E.coli
were used and template DNA came from DNA extraction of a 108 CFU/ml
culture in BHI.
The detection protocol is described in Section 3.3. From the 36 silicon ox-
ide wells, 18 were positive controls and 18 negative controls. As is it showed
in Figure 4.1, all positive controls exceeded the fluorescence threshold (no
false positives) and none of the negative controls showed any fluorescence in-
crease. This demonstrates that the experimental protocol for on-chip LAMP
amplification of DNA is successful. Using droplets of 30 nL and Sigmacote for
silicon oxide passivation allows detection of pathogenic agents through DNA
isothermal amplification. Figure 4.1.a and 4.1.b show fluorescence images
before and after amplification. It is possible to see that only ‘Full’ samples
increased fluorescence, indicating positive amplification. Figure 4.1.c plots
recorded normalized fluorescence intensity in each well as a function of time
for real-time amplification analysis.
We observed fast detection times with an average of less than 10 min.
However, fast detection time is explained by a high concentration of template
that comes from DNA extraction of a 108 CFU/ml culture. Amplification
is also uniform; threshold time standard deviation is less than 3 minutes.
The following sections show characterization experiments for this detection
method.
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Figure 4.1: On-chip detection of E.coli O157:H7 after primer dehydration.
Target gene for amplification was stx2 . Dotted lines represent negative
controls while continuous lines are full samples. Rows are labeled as literals
and columns as numerals.
4.2 Sensitivity, template dilution experiments
Experiments to determine the minimum detectable bacteria concentration
were done by injecting LAMP solution with different initial template concen-
tration in each column of the 6x6 silicon oxide well array. Serial logarithmic
dilutions of bacterium lysate were used as the DNA template, modifying the
initial concentration from 109 CFU/ml to 105 CFU/ml. This would yield
30000 copies/well and 3 copies/well respectively. Amplification time was 60
min and fluorescence intensity was recorded every minute.
Figure 4.2 shows the progression of fluorescence images during ampli-
fication when samples reach the threshold fluorescence. Figure 4.3 plots
the derivative of fluorescence intensity for threshold time analysis (threshold
time is recorded when derivative peaks) and bar plots of threshold times for
different template concentrations.
As expected, samples with larger initial template concentration had faster
threshold time and lower false positive ratio. Higher initial template con-
centration allows primers to bind to multiple copies and quickly create more
dsDNA, which translates into a low threshold time. In addition, low ini-
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Figure 4.2: Sequence of fluorescence images in sensitivity experiments.
Concentration of template copies in each well decreases from 30,000 to 3.
Column on the right is for no template negative control.
tial concentrations of template may result in few or no template copies in
nano-wells, explaining the increase of false negatives with lower template
concentrations. This experiment states that current detection limit is 106
CFU/ml or 30 copies per reaction well. Since LAMP has been reported to
amplify as low as one template copy per reaction [43], we expect that im-
proved surface passivation and DNA extraction protocols will improve the
detection limit to 105 CFU/ml (3 copies per reaction well) with low false
negative ratio.
4.3 Robustness, primer dehydration
Primer dehydration and amplification reliability was tested with experiments
in which primers were spotted in silicon oxide wells and then frozen for days
before amplification. These experiments demonstrate that it is possible to
store passivated chips with loaded primers up to 5 days and still be able to
detect the presence of pathogens. The protocol described in Section 3.3 was
interrupted after primer dehydration. The chip was frozen at −20 ◦C and
then after 3 and 5 days, it was used for on-chip LAMP amplification. Figure
4.4 shows on-chip amplification of E.coli O157:H7 stx2 gene after primers
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Figure 4.3: Sensitivity experiments: a) Derivative of fluorescence intensity
for threshold time analysis. b) Bar plot and false negative ratio for multiple
concentrations.
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were dehydrated and frozen for 3 days, and Figure 4.5 shows amplification
after primers were dehydrated for 5 days. Both show amplification for full
samples, but it is also possible to observe that amplification performance is
harmed when primers are dehydrated.
When Figure 4.1 and Figure 4.4 are compared, it is obvious that ampli-
fication after primers are frozen is less uniform (threshold time variation is
2 times larger) and some of the wells did not show a sigmoidal fluorescence
increase, suggesting non-specific amplification. Therefore, it is possible to
conclude that, after 3 days of primers being dried, it is still possible to do
on-chip detection, but at the cost of worse amplification performance and
reliability. Similar observations are recorded after 5 days of dehydration.
There is also amplification in full samples, but real time fluorescence data
suggest nonspecific amplification.
Figure 4.4: On-chip detection of E.coli O157 after primers being dried and
frozen for 3 days
4.4 Parallel detection of multiple pathogens
Primer dehydration techniques proved to be sensitive and robust. Exper-
iments in previous sections demonstrated that primers can be dehydrated,
stored for days, and still be able to detect the presence of pathogens through
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Figure 4.5: On-chip detection of E.coli O157 after primers being dried and
frozen for 5 days
DNA amplification techniques. In this experiment we demonstrate that on-
chip LAMP amplification after primer dehydration is also specific. With the
microinjection protocol there is low or no cross-contamination between wells,
allowing screening of multiple pathogens in a single experiment if multiple
primers are dehydrated in a single array. Primer dehydration protocol (Fig-
ure 3.8) was followed to dehydrate primers for salmonella, L.monocytogenes
and E.coli. Twelve positions, two consecutive columns, are preloaded with
dried primers for each of the three pathogens. Afterwards a primer-free
LAMP solution with E.coli O157 template (extracted from a 108 CFU/ml
culture) was injected in all silicon oxide wells. Results are presented in Fig-
ure 4.6; only wells with primers that match the injected template showed
positive amplification.
Having multiple primers dehydrated on silicon oxide wells allows parallel
screening of multiple pathogens in a single array. This will reduce the amount
of labor, time of identification and reagent consumption for detection and
identification of several foodborne pathogens. This process, done here for
three pathogens, can be easily scaled to several more by augmenting the
number of wells in the array and dehydrating a larger number of primers.
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Figure 4.6: Multiplexed screening of E.coli O157, L. monocytogenes and
salmonella in one assay demonstrating specific detection of pathogen
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CHAPTER 5
CONCLUSIONS
We have demonstrated sensitive and specific LAMP amplification of virulent
foodborne pathogen genes in a silicon oxide microchip. Performing biomolec-
ular reactions in silicon-based materials allows integration of semiconductor
technologies and biomolecular methods. This will enable development of
NA-POC devices that are smaller, cheaper and more robust.
A customized experimental setup composed of an automated microinjec-
tion system and a fluorescence microscope was used to fill micromachined
silicon oxide wells with 30 nL of LAMP solutions. Then nucleic acid ampli-
fication was carried out on-chip using a heated stage and the amplification
was monitored with fluorescence microscopy. Using this experimental setup,
we observed nucleic acid amplification after primers were dehydrated and
frozen up to 5 days. So far, prior to optimization of passivation protocols
and DNA extraction, the detection limit of this protocol is 106 CFU/ml or 30
copies/reaction. Specificity of LAMP and negligible cross-contamination be-
tween wells when droplets are microinjected allowed us to screen for multiple
pathogens in a single assay.
The development of a NA-POC tester is ongoing. The next steps in the
development of a fully integrated system are as follows:
• The template used for reported results should not come from DNA
extraction protocols. It is necessary to test LAMP amplification with
cell lysate (no extraction protocols) to discard inhibitory effects of other
cell components and evaluate amplification performance.
• In future iterations of silicon oxide wells, deeper wells must be etched
so mineral oil can be confined to each well. This will simplify the
microinjection process and reduce the chance of contamination between
samples.
• Is desirable to experiment the minimum droplet volume where posi-
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tive amplification takes place. Reducing the droplet volume and well
size will increase the density of wells, thereby allowing screening of
more pathogens. However, smaller droplets will have larger surface-to-
volume ratio and surface inhibitory effects will be more significant.
• Integration of silicon oxide wells with field-effect transistors (having
one or multiple transistors at the bottom of the well) will allow local-
ized heating for reduced power consumption and electrical detection of
LAMP products for label-free, optics-free, amplification detection. In-
tegrating FET heaters and sensors will exploit advantages of biomolec-
ular/semiconductor integration, showing a clear path for an effective
NA-POC tester.
40
APPENDIX A
MATLAB SCRIPT FOR AUTOMATION OF
MICROINJECTION SYSTEM
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APPENDIX B
MATLAB SCRIPT FOR REAL-TIME
FLUORESCENCE DETECTION,
AUTOMATED SHUTTER AND CAMERA
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APPENDIX C
MATLAB SCRIPT FOR DATA ANALYSIS
OF FLUORESCENCE INTENSITY
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